# Uscb Financial Holdings, Inc.: financial statements, quarterly

USCB · Nasdaq · CIK 1901637 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uscb.md) · [Financials](/companies/uscb/financials.md) · [Filings](/companies/uscb/filings.md) · [Insiders](/companies/uscb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uscb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [12.4](/filings/0001562762-23-000414.md) | [13.6 d](/filings/0001562762-24-000061.md) | [15.7](/filings/0001562762-24-000138.md) | [15.3](/filings/0001562762-24-000207.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.3](/filings/0001562762-24-000269.md) | [0.8 d](/filings/0001562762-25-000043.md) | [1.4](/filings/0001562762-25-000122.md) | [2.0](/filings/0001562762-25-000206.md) | [2.2](/filings/0001562762-25-000269.md) | [2.2 d](/filings/0001562762-26-000027.md) | [2.4](/filings/0001562762-26-000062.md) | [2.6](/filings/0001562762-26-000090.md) | [2.9](/filings/0001562762-25-000269.md) | [1.9 d](/filings/0001562762-26-000027.md) | [2.3](/filings/0001562762-26-000062.md) | [3.6](/filings/0001562762-26-000090.md) |
| Net income | $m | [3.8](/filings/0001562762-24-000269.md) | [2.7 d](/filings/0001562762-25-000043.md) | [4.6](/filings/0001562762-25-000122.md) | [6.2](/filings/0001562762-25-000206.md) | [6.9](/filings/0001562762-25-000269.md) | [6.9 d](/filings/0001562762-26-000027.md) | [7.7](/filings/0001562762-26-000062.md) | [8.1](/filings/0001562762-26-000090.md) | [8.9](/filings/0001562762-25-000269.md) | [1.4 d](/filings/0001562762-26-000027.md) | [9.4](/filings/0001562762-26-000062.md) | [9.1](/filings/0001562762-26-000090.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [0.35](/filings/0001562762-25-000269.md) | not reported | [0.38](/filings/0001562762-26-000062.md) | [0.40](/filings/0001562762-26-000090.md) | [0.45](/filings/0001562762-25-000269.md) | not reported | [0.51](/filings/0001562762-26-000062.md) | [0.49](/filings/0001562762-26-000090.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [0.35](/filings/0001562762-25-000269.md) | not reported | [0.38](/filings/0001562762-26-000062.md) | [0.41](/filings/0001562762-26-000090.md) | [0.46](/filings/0001562762-25-000269.md) | not reported | [0.51](/filings/0001562762-26-000062.md) | [0.49](/filings/0001562762-26-000090.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [33.4](/filings/0001562762-23-000414.md) | [41.1](/filings/0001562762-25-000043.md) | [127](/filings/0001562762-24-000138.md) | [77.3](/filings/0001562762-24-000207.md) | [38.5](/filings/0001562762-24-000269.md) | [77.0](/filings/0001562762-26-000027.md) | [98.0](/filings/0001562762-25-000122.md) | [54.8](/filings/0001562762-25-000206.md) | [56.8](/filings/0001562762-25-000269.md) | [38.5](/filings/0001562762-26-000090.md) | [79.0](/filings/0001562762-26-000062.md) | [118](/filings/0001562762-26-000090.md) |
| Total assets | $m | [2,245](/filings/0001562762-23-000414.md) | [2,339](/filings/0001562762-25-000043.md) | [2,489](/filings/0001562762-24-000138.md) | [2,458](/filings/0001562762-24-000207.md) | [2,504](/filings/0001562762-24-000269.md) | [2,581](/filings/0001562762-26-000027.md) | [2,677](/filings/0001562762-25-000122.md) | [2,719](/filings/0001562762-25-000206.md) | [2,768](/filings/0001562762-25-000269.md) | [2,792](/filings/0001562762-26-000090.md) | [2,846](/filings/0001562762-26-000062.md) | [3,020](/filings/0001562762-26-000090.md) |
| Total liabilities | $m | [2,062](/filings/0001562762-23-000414.md) | [2,147](/filings/0001562762-25-000043.md) | [2,294](/filings/0001562762-24-000138.md) | [2,257](/filings/0001562762-24-000207.md) | [2,290](/filings/0001562762-24-000269.md) | [2,366](/filings/0001562762-26-000027.md) | [2,452](/filings/0001562762-25-000122.md) | [2,488](/filings/0001562762-25-000206.md) | [2,559](/filings/0001562762-25-000269.md) | [2,574](/filings/0001562762-26-000090.md) | [2,622](/filings/0001562762-26-000062.md) | [2,786](/filings/0001562762-26-000090.md) |
| Shareholders' equity | $m | [183](/filings/0001562762-24-000269.md) | [192](/filings/0001562762-26-000027.md) | [195](/filings/0001562762-25-000206.md) | [201](/filings/0001562762-25-000269.md) | [214](/filings/0001562762-25-000269.md) | [215](/filings/0001562762-26-000090.md) | [225](/filings/0001562762-26-000090.md) | [232](/filings/0001562762-26-000090.md) | [209](/filings/0001562762-25-000269.md) | [217](/filings/0001562762-26-000090.md) | [223](/filings/0001562762-26-000090.md) | [233](/filings/0001562762-26-000090.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.3 d](/filings/0001562762-24-000269.md) | [(6.0) d](/filings/0001562762-25-000043.md) | [8.1](/filings/0001562762-25-000122.md) | [18.3 d](/filings/0001562762-25-000206.md) | [11.3 d](/filings/0001562762-25-000269.md) | [(2.9) d](/filings/0001562762-26-000027.md) | [14.6](/filings/0001562762-26-000062.md) | [18.0 d](/filings/0001562762-26-000090.md) | [20.1 d](/filings/0001562762-25-000269.md) | [(10.0) d](/filings/0001562762-26-000027.md) | [15.3](/filings/0001562762-26-000062.md) | [24.7 d](/filings/0001562762-26-000090.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001562762-24-000269.md) | [0.0 d](/filings/0001562762-25-000043.md) | [0.1](/filings/0001562762-25-000122.md) | [0.1 d](/filings/0001562762-25-000206.md) | [0.1 d](/filings/0001562762-25-000269.md) | [0.1 d](/filings/0001562762-26-000027.md) | [0.0](/filings/0001562762-26-000062.md) | [0.0 d](/filings/0001562762-26-000090.md) | [0.1 d](/filings/0001562762-25-000269.md) | [0.1 d](/filings/0001562762-26-000027.md) | [0.3](/filings/0001562762-26-000062.md) | [0.4 d](/filings/0001562762-26-000090.md) |
| Dividends paid | $m | not reported | not reported | [1.0](/filings/0001562762-25-000122.md) | [1.0 d](/filings/0001562762-25-000206.md) | [1.0 d](/filings/0001562762-25-000269.md) | [0.9 d](/filings/0001562762-26-000027.md) | [2.0](/filings/0001562762-26-000062.md) | [2.0 d](/filings/0001562762-26-000090.md) | [2.0 d](/filings/0001562762-25-000269.md) | [1.8 d](/filings/0001562762-26-000027.md) | [2.3](/filings/0001562762-26-000062.md) | [2.3 d](/filings/0001562762-26-000090.md) |
| Share repurchases | $m | [0.0 d](/filings/0001562762-24-000269.md) | [1.0 d](/filings/0001562762-25-000043.md) | [0.1](/filings/0001562762-25-000122.md) | [0.3 d](/filings/0001562762-25-000206.md) | [0.1 d](/filings/0001562762-25-000269.md) | [0.0 d](/filings/0001562762-26-000027.md) | [0.2](/filings/0001562762-26-000062.md) | [0.0 d](/filings/0001562762-26-000090.md) | [34.4 d](/filings/0001562762-25-000269.md) | [0.0 d](/filings/0001562762-26-000027.md) | [1.0](/filings/0001562762-26-000062.md) | [0.0 d](/filings/0001562762-26-000090.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 18,474,470 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001562762-26-000090.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.